European Countries Should Join Forces To Lower Prices of Zolgensma & Kaftrio
The Dutch HTA institute is calling for hefty discounts of 50% and 75% for Novartis’s gene therapy and Vertex’s cystic fibrosis product.
You may also be interested in...
Two groups of smaller European countries have agreed to collaborate on tackling challenges relating to accessing expensive new medicines.
Biogen, the first company to win a positive reimbursement decision from the BeNeLuxA groups, says the process was “constructive and collaborative.” However, differences in local laws mean there will initially be some differences in coverage.
The European Parliament and EU Council have reached an agreement on taking forward proposals for greater cooperation on health technology assessments.